Questions discussed in this category
When do you determine SSRI therapy is unsafe to pursue in such situations?
HFE gene mutations in C282Y and H63D are negative.
Should they be placed on routine EGD surveillance and if yes at what intervals?
When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?
1984119902134611481410363
Papers discussed in this category
J Pharm Pract, 2019 Mar 27
Pharmacological research, 2016 Aug 10
The Annals of pharmacotherapy, 2018 Aug 06
Am J Gastroenterol,
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2016 Nov
Journal of hepatology, 2022 Jun 01